Table 2.
| |
Clinical presentation | Unilateral 89% (n = 38) |
Palpebral edema 88% (n = 38) | |
Conjunctival congestion 81% (n = 35) | |
Chemosis 79% (n = 34) | |
Ocular pain 77% (n = 33) | |
Motility impairment 65% (n = 28) | |
Proptosis 56% (n = 24) | |
Blurred vision 39% (n = 17) | |
Complications | AION 2.32% (n = 1) |
Type of treatment | Systemic corticoid 72% (n = 31) |
Oral Prednisolone alone 48.83% (n = 21) | |
Methylprednisolone EV + Oral Prednisolone 23.25% (n = 10) | |
Solve spontaneously 11.63% (n = 5) | |
Without data 9.30 (n = 4) | |
NSAIDs 4.65 % (n = 2) | |
Topic Prednisolone 2.23% (n = 1) | |
AION, anterior ischemic optic neuritis; NSAIDs, nonsteroids anti-inflammatory drugs |